Journal of the American Chemical Society / JAMA / 破産手続廃止及び免責許可決定
令和8年1月5日|p.18
左の本文を選ぶと、右側の官報原文画像で該当箇所を照合できます。
報
破産手続廃止及び免責許可決定
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
535 NORTH DEARBORN STREET - CHICAGO 10, ILL.
Cable Address: "Medic, Chicago"
Subscription price: Fifteen dollars per annum in advance
Please send in promptly notice of change of address, giving both old and new; always state whether local or foreign.
SATURDAY, NOVEMBER 17, 1951
TREATMENT OF TUBERCULOSIS
The treatment of tuberculosis has undergone a revolution in the last few years. The introduction of streptomycin and para-aminosalicylic acid (PAS) has made it possible to treat this disease with drugs that are effective against the tubercle bacillus. These drugs have been used in combination with other measures such as rest, nutrition, and surgery. The results have been encouraging, and many patients have been cured or have shown significant improvement.
However, the use of these drugs is not without its problems. Resistance to streptomycin can develop, and PAS can cause side effects such as gastrointestinal disturbances and allergic reactions. Therefore, careful monitoring of patients is necessary to ensure that the treatment is effective and safe.
In addition to drug therapy, other measures such as rest, nutrition, and surgery are still important in the treatment of tuberculosis. Rest is essential for the recovery of the patient, and proper nutrition is necessary to maintain the patient's strength and resistance to infection. Surgery may be necessary in some cases to remove infected tissue or to correct complications of the disease.
The treatment of tuberculosis requires a multidisciplinary approach involving physicians, nurses, and other healthcare professionals. It is important to provide comprehensive care to the patient, including psychological support and social services. The goal of treatment is not only to cure the disease but also to improve the quality of life of the patient.
In conclusion, the treatment of tuberculosis has made significant progress in recent years with the introduction of new drugs and improved understanding of the disease. However, challenges remain, and continued research and development are needed to further improve the treatment of this disease.